<< Back to News

FDA Approval of LORBRENA® (lorlatinib)

Pfizer Oncology is proud to announce the FDA approval of LORBRENA® (lorlatinib) on Friday, November 2, 2018.

Click here  to read the Press Release.

Visit LORBRENA U.S. Physician Prescribing Information to read the full PI.